<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="lactones isolated from medicinal plants in the treatment of the" exact="metabolic syndrome" post="â€&quot; A review Salazar-GÃ³mezAnuaraOntiveros-RodrÃ­guezJulio C.bPablo-PÃ©rezSaudy S.aVargas-DÃ­azM. ElenacGarduÃ±o-SicilianoLeticiaaâ�Ž[a], [b], [c],"/>
 <result pre="COVID-19 resource centre remains active. Highlights â€¢Definition and pathogenesis of" exact="metabolic syndrome" post="is briefly described. â€¢Sesquiterpene lactones isolated from medicinal plants"/>
 <result pre="a cluster of metabolic disorders related to the development of" exact="cardiovascular disease" post="and type 2 diabetes mellitus. In latter years, plant"/>
 <result pre="related to the development of cardiovascular disease and type 2" exact="diabetes mellitus." post="In latter years, plant secondary metabolites have become of"/>
 <result pre="interest because of their potential role in preventing and managing" exact="metabolic syndrome." post="Sesquiterpene lactones constitute a large and diverse group of"/>
 <result pre="validated for their biological activities related to risk factors of" exact="metabolic syndrome," post="together with their mechanisms of action. The potential beneficial"/>
 <result pre="biological activity, providing new insights into the possible role in" exact="metabolic syndrome" post="management. Keywords Sesquiterpene lactones Medicinal plants Metabolic syndrome Hypoglycemic"/>
 <result pre="C3 AT, adipose tissue CAT, catalase COX-2, cyclooxygenase 2 CVD," exact="cardiovascular disease" post="FFA, free fatty acids FN, fibronectin G6Pase, glucose-6-phosphatase GK,"/>
 <result pre="MAPK, mitogen-activated protein kinases MCP-1, monocyte chemoattractant protein 1 MetS," exact="metabolic syndrome" post="NF-ÎºB, nuclear factor kappa B NO, nitric oxide ROS,"/>
 <result pre="and activator of transcription 1 STZ, streptozotocin T2DM, type 2" exact="diabetes mellitus" post="TBARS, thiobarbituric acid reactive substances TC, total cholesterol TG,"/>
 <result pre="a cluster of risk factors related to the development of" exact="cardiovascular disease" post="(CVD) and type 2 diabetes mellitus (T2DM) (AlbertiÂ etÂ"/>
 <result pre="to the development of cardiovascular disease (CVD) and type 2" exact="diabetes mellitus" post="(T2DM) (AlbertiÂ etÂ al., 2009). This pathological condition represents"/>
 <result pre="that influences progression and prognosis of coronavirus disease 2019, the" exact="infectious disease" post="caused by the most recently discovered coronavirus SARS-CoV-2 (CostaÂ"/>
 <result pre="June 2020 using the keyword sesquiterpene lactones and following terms:" exact="metabolic syndrome," post="hypoglycemic, hypolipidemic, antidiabetic, antihypertensive, and medicinal plants. Additional information"/>
 <result pre="Germacrolide Costus speciosus 6 Alantolactone Eudesmanolide Inula helenium Antiinflammatory-associated to" exact="glucose intolerance" post="and IR (in vitro) Antiinflamatory- obesity-induced IR (in vitro)"/>
 <result pre="vitro) Attenuates lipid accumulation (in vitro) Antiinflamatory- associated to diabetic" exact="nephropathy" post="(in vivo) STAT3 inhibitor. Inhibition of the TLR4 gene"/>
 <result pre="ether 13 Micheliolide Guaianolide Magnolia compressa Anti-inflammatory- associated to diabetic" exact="nephropathy" post="(in vitro)Anti-hepatic steatosis (in vivo and in vitro) Suppressed"/>
 <result pre="disorders (KlÃ¶tingÂ and BlÃ¼her,Â 2014). Body fat mass accumulation in" exact="obesity" post="depends on different factors including the relationship of energy"/>
 <result pre="global metabolic effect of insulin resistance. Chronic low-grade inflammation in" exact="obesity" post="results from the activation of various inflammatory mechanisms through"/>
 <result pre="that enhydrin (1) is effective in the management of post-prandial" exact="hyperglycemia" post="through inhibition of Î±-glucosidase in the small intestine (Serra-BarcellonaÂ"/>
 <result pre="melampolide 2 could be effective in the management of postprandial" exact="hyperglycemia" post="through inhibition of Î±-glucosidase. However, no studies of these"/>
 <result pre="not produce adverse nutritional effect. No gastrointestinal symptom such as" exact="diarrhea" post="or constipation were observed at the doses assayed. Volume,"/>
 <result pre="adverse nutritional effect. No gastrointestinal symptom such as diarrhea or" exact="constipation" post="were observed at the doses assayed. Volume, pH and"/>
 <result pre="of the extract, potential activity of this molecule in managing" exact="dyslipidemia" post="may be proposed. However, additional studies are needed to"/>
 <result pre="shown to suppress LPS-induced NF-ÎºB activation that leads to the" exact="suppression" post="of iNOS and a consequent nonproduction of NO. This"/>
 <result pre="TLRs are responsible for the activation of inflammatory pathways in" exact="obesity" post="state. In vitro trials confirmed that alantolactone (6) prevents"/>
 <result pre="cells. In this context, the compound 6 inhibits IL-6-induced insulin-stimulated" exact="glucose intolerance" post="and insulin resistance in the skeletal muscle through blockade"/>
 <result pre="complications on e.g. modulating hepatic IL-6/STAT3 signaling in high-fat diet-induced" exact="metabolic disorder" post="in animal models, since the physiological metabolic response to"/>
 <result pre="authors to propose a beneficial use for the treatment of" exact="diabetic neuropathy." post="Taking together all evidences mentioned for alantolactone (6) activity,"/>
 <result pre="is a contact allergen, and in vitro is cytotoxic in" exact="cancer" post="cells and induces apoptosis (Tisserand and Young,Â 2014). 6.6"/>
 <result pre="indigenous people for treating a wide spectrum of diseases, including" exact="diabetes mellitus." post="Several in vitro and in vivo studies have stated"/>
 <result pre="and PPAR-Î³ agonists; and may also be used to treat" exact="dyslipidemia" post="and T2DM simultaneously (BalakumarÂ etÂ al., 2019). Tirotundin (7)"/>
 <result pre="and their components have been related to ameliorate characters of" exact="obesity" post="and diabetes, such as hyperglycemia, hyperlipidemia, and other complications"/>
 <result pre="to be more potently cytotoxic than their monomers toward human" exact="cancer" post="cells, indicating that the antitumor potential of SLns are"/>
 <result pre="L. scariola L.) have been used in the treatment of" exact="diabetes mellitus," post="hypertension, and cardiac diseases (EddouksÂ etÂ al., 2002; Subramoniam,Â"/>
 <result pre="and widely used in India as a traditional treatment for" exact="diabetes mellitus" post="(Al-Snafi,Â 2016; PushparajÂ etÂ al., 2007). The antidiabetic, hypolipidemic,"/>
 <result pre="18 and their derivatives are part of the protocols for" exact="malaria" post="treatment (BridgfordÂ etÂ al., 2018). Experimental studies have also"/>
 <result pre="etÂ al., 2018) properties. A. scoparia ethanolic extract reduces non-alcoholic" exact="fatty liver disease" post="by enhancing hepatic insulin and AMP-AMPK signaling in diet-induced"/>
 <result pre="al., 2018) properties. A. scoparia ethanolic extract reduces non-alcoholic fatty" exact="liver disease" post="by enhancing hepatic insulin and AMP-AMPK signaling in diet-induced"/>
 <result pre="common clinical condition in countries with a high incidence of" exact="obesity" post="and western dietary patterns. Natural products, such as SLns,"/>
 <result pre="in vitro. American Journal of PhysiologyEndocrinology and Metabolism31552018E1053E106110.1152/ajpendo.00177.201830153067 BridgfordJ.L.XieS.C.CobboldS.A.PasajeC.F.A.HerrmannS.YangT.GillettD.L.DickL.R.RalphS.A.DogovskiC.SpillmanN.J.TilleyL.Artemisinin kills" exact="malaria" post="parasites by damaging proteins and inhibiting the proteasomeNature Communications92018380110.1038/s41467-018-06221-1"/>
 <result pre="as a food supplement: health-promoting benefits of fructooligosaccharidesNutrients87201643610.3390/nu8070436 CaoQ.DuH.FuX.DuanN.LiuC.LiX.Artemisinin attenuated" exact="atherosclerosis" post="in high-fat diet-fed ApoE-/- mice by promoting macrophage autophagy"/>
 <result pre="EddouksM.MaghraniM.LemhadriA.OuahidiM.-.L.JouadH.Ethnopharmacological survey of medicinal plants used for the treatment of" exact="diabetes mellitus," post="hypertension and cardiac diseases in the south-east region of"/>
 <result pre="ancient herb to modern drug: Artemisia annua and artemisinin for" exact="cancer" post="therapySeminars in Cancer Biology462017658310.1016/j.semcancer.2017.02.00928254675 EfferthT.KainaB.Toxicity of the antimalarial artemisinin"/>
 <result pre="in STZ-induced diabetic ratsChemico-Biological Interactions1822009677210.1016/j.cbi.2009.08.01219695236 EnginA.The definition and prevalence of" exact="obesity" post="and metabolic syndromeEnginA.B.EnginA.Obesity and Lipotoxicity. Advances in Experimental Medicine"/>
 <result pre="Chemistry of Organic Natural Products381979SpringerVienna4732010.1007/978-3-7091-8548-3_2 Francini-PesentiF.SpinellaP.CalÃ²L.A.Potential role of phytochemicals in" exact="metabolic syndrome" post="prevention and therapyDiabetes, Metabolic Syndrome and Obesity: Targets and"/>
 <result pre="most active fractionsChemico-Biological Interactions185201014315210.1016/j.cbi.2010.03.00420211156 Gomez-HernandezA.BeneitN.Diaz-CastroverdeS.EscribanoO.Differential role of adipose tissues in" exact="obesity" post="and related metabolic and vascular complicationsInternational Journal of Endocrinology2016201610.1155/2016/1216783"/>
 <result pre="glycoside from Lactuca indicaJournal of Natural Products665200362562910.1021/np0205349https://pharmacologyonline.silae.it/files/archives/2009/vol3/013.HARESH.pdf12762795 IqbalJ.Al QarniA.HawwariA.AlghanemA.F.AhmedG.Metabolic syndrome," exact="dyslipidemia" post="and regulation of lipoprotein metabolismCurrent Diabetes Reviews145201842743310.2174/157339981366617070516103928677496 IvanescuB.MironA.CorciovaA.Sesquiterpene lactones"/>
 <result pre="TGF-Î²1 expression in rat mesangial cellsMolecules18102013130611307710.3390/molecules18101306124152676 JiangW.CenY.SongY.LiP.QinR.LiuC.ZhaoY.ZhengJ.ZhouH.Artesunate attenuated progression of" exact="atherosclerosis" post="lesion formation alone or combined with rosuvastatin through inhibition"/>
 <result pre="JoshiT.SinghA.K.HaratipourP.SahA.N.PandeyA.K.NaseriR.JuyalV.FarzaeiM.H.Targeting AMPK signaling pathway by natural products for treatment of" exact="diabetes mellitus" post="and its complicationsJournal of Cellular Physiology234102019172121723110.1002/jcp.2852830916407 JuS.Y.LeeJ.Y.KimD.H.Association of metabolic"/>
 <result pre="diabetes mellitus and its complicationsJournal of Cellular Physiology234102019172121723110.1002/jcp.2852830916407 JuS.Y.LeeJ.Y.KimD.H.Association of" exact="metabolic syndrome" post="and its components with all-cause and cardiovascular mortality in"/>
 <result pre="annua LKorean Journal of Physiology &amp;amp; Pharmacology1912015212710.4196/kjpp.2015.19.1.2125605993 KimM.SongK.KimY.S.Alantolactone improves palmitate-induced" exact="glucose intolerance" post="and inflammation in both lean and obese states in"/>
 <result pre="KimM.SongK.KimY.S.Alantolactone improves prolonged exposure of interleukin-6-induced skeletal muscle inflammation associated" exact="glucose intolerance" post="and insulin resistanceFrontiers in Pharmacology8201740510.3389/fphar.2017.0040528706484 KisielW.GromekD.Sesquiterpene lactones from Lactuca"/>
 <result pre="Plant Sciences3512016183710.1080/07352689.2016.1145956 PalM.FebbraioM.A.LancasterG.I.The roles of câ€�Jun NH2â€�terminal kinases (JNKs) in" exact="obesity" post="and insulin resistanceThe Journal of Physiology5942201626727910.1113/JP27145726608096 ParkH.H.KimM.J.LiY.ParkY.N.LeeJ.LeeY.J.KimS.G.ParkH.J.SonJ.K.ChangH.W.LeeE.Britanin suppresses LPS-induced"/>
 <result pre="a new source of antidiabetic compoundsChemico-Biological Interactions2092014354710.1016/j.cbi.2013.11.01524309157 Serra-BarcellonaC.HabibN.C.HonoreS.M.SÃ¡nchezS.S.GentaS.B.Enhydrin regulates postprandial" exact="hyperglycemia" post="in diabetic rats by inhibition of Î±-glucosidase activityPlant Foods"/>
 <result pre="and biosynthesisRamawatK.MÃ©rillonJ.M.Natural Products2013SpringerBerlin, Heidelberg3069309810.1007/978-3-642-22144-6_134 SinghN.P.LaiH.C.ParkJ.S.GerhardtT.E.KimB.J.WangS.SasakiT.Effects of artemisinin dimers on rat" exact="breast cancer" post="cells in vitro and in vivoAnticancer Research3112201141114114http://ar.iiarjournals.org/content/31/12/4111.short22199268 SousaS.PintoJ.RodriguesC.GiÃ£oM.PereiraC.TavariaF.PintadoM.Antioxidant properties"/>
 <result pre="biosynthesisRamawatK.MÃ©rillonJ.M.Natural Products2013SpringerBerlin, Heidelberg3069309810.1007/978-3-642-22144-6_134 SinghN.P.LaiH.C.ParkJ.S.GerhardtT.E.KimB.J.WangS.SasakiT.Effects of artemisinin dimers on rat breast" exact="cancer" post="cells in vitro and in vivoAnticancer Research3112201141114114http://ar.iiarjournals.org/content/31/12/4111.short22199268 SousaS.PintoJ.RodriguesC.GiÃ£oM.PereiraC.TavariaF.PintadoM.Antioxidant properties"/>
 <result pre="SunJ.WangY.FuX.ChenY.WangD.LiW.XingS.LiG.Magnolia officinalis extract contains potent inhibitors against PTP1B and attenuates" exact="hyperglycemia" post="in db/db miceBioMed Research International201513945110.1155/2015/139451 SunZ.LiG.TongT.ChenJ.Micheliolide suppresses LPS-induced neuroinflammatory"/>
 <result pre="activityExpert Opinion on Investigational Drugs233201431734510.1517/13543784.2014.86888224387187 WangZ.Q.ZhangX.H.YuY.TiptonR.C.RaskinI.RibnickyD.JohnsonW.CefaluW.T.Artemisia scoparia extract attenuates nonalcoholic" exact="fatty liver disease" post="in diet-induced obesity mice by enhancing hepatic insulin and"/>
 <result pre="Opinion on Investigational Drugs233201431734510.1517/13543784.2014.86888224387187 WangZ.Q.ZhangX.H.YuY.TiptonR.C.RaskinI.RibnickyD.JohnsonW.CefaluW.T.Artemisia scoparia extract attenuates nonalcoholic fatty" exact="liver disease" post="in diet-induced obesity mice by enhancing hepatic insulin and"/>
 <result pre="WangZ.Q.ZhangX.H.YuY.TiptonR.C.RaskinI.RibnickyD.JohnsonW.CefaluW.T.Artemisia scoparia extract attenuates nonalcoholic fatty liver disease in diet-induced" exact="obesity" post="mice by enhancing hepatic insulin and AMPK signaling independently"/>
 <result pre="p65 with a helenalin inspired bis-electrophileACS Chemical Biology121201710211310.1021/acschembio.6b0075128103680 XuH.LiX.AdamsH.KubenaK.GuoS.Etiology of" exact="metabolic syndrome" post="and dietary interventionInternational Journal of Molecular Sciences201201912810.3390/ijms20010128 YangM.ZhaoH.AiH.ZhuH.WangS.BaoY.LiY.Alantolactone suppresses"/>
 <result pre="and Human Wellness33-4201413617410.1016/j.fshw.2014.11.003 YungJ.H.M.GiaccaA.Role of c-Jun N-terminal Kinase (JNK) in" exact="obesity" post="and type 2 diabetesCells93202070610.3390/cells9030706 ZeggwaghN.A.OuahidiM.L.LemhadriA.EddouksM.Study of hypoglycaemic and hypolipidemic"/>
</results>
